Download Handouts: https://bit.ly/41Jsswf

When considering the sublingual route of administration for semaglutide, it is important to understand the available science, plus clinical and legal considerations. Join us for this free, non-CE webinar to stay informed and provide enhanced care.

What you'll learn:
Practical Insights: PCCA Clinical Compounding Pharmacist Sebastian Denison, RPh, will discuss dosing considerations, safety information including potential side effects, advantages and challenges of sublingual administration, and transitioning from other dosage forms to sublingual administration.

Microdosing Considerations: PCCA Clinical Compounding Pharmacist Catherine Henderson, PharmD, will provide a comprehensive understanding of GLP-1, clinical applications, and the potential benefits and challenges of microdosing.

Regulatory Updates: PCCA Vice President of Clinical Services Matt Martin, PharmD, BCSCP, will address the current legal and regulatory landscape surrounding compounding GLP-1 medications.

Don’t miss this opportunity to deepen your understanding and improve patient outcomes.

Speakers:

Sebastian Denison, RPh
Catherine Henderson, PharmD
Matt Martin, PharmD, BCSCP